| LOSS / EARNINGS PER SHARE |
NOTE 8 LOSS / EARNINGS
PER SHARE
Basic loss/earnings per share
data for each period presented is computed using the weighted average number of shares of common stock outstanding during each such period
and includes pre-funded warrants from their date of issuance. Diluted loss/earnings per share data is computed using the weighted average
number of common and dilutive common equivalent shares outstanding during each period. Dilutive common equivalent shares consist of shares
that would be issued upon the exercise of stock options and warrants, computed using the treasury stock method.
A reconciliation of basic and diluted earnings/loss
per share is as follows:
| Schedule of reconciliation of basic and diluted earnings per share | |
| |
| |
| |
|
| | |
For the Three Months Ended | |
For the Nine Months Ended |
| | |
June 30, | |
June 30, |
| | |
2026 | |
2025 | |
2026 | |
2025 |
| Numerator: | |
| |
| |
| |
|
| Loss from continuing operations | |
$ | (68,959,000 | ) | |
$ | (2,404,000 | ) | |
$ | (937,692,000 | ) | |
$ | (5,124,000 | ) |
| Less deemed dividend on Series B Convertible Preferred Stock | |
| – | | |
| (10,000 | ) | |
| – | | |
| (10,000 | ) |
| Loss from continuing operations attributable to common shareholders | |
| (68,959,000 | ) | |
| (2,414,000 | ) | |
| (937,692,000 | ) | |
| (5,134,000 | ) |
| Income from discontinued operations, net of tax | |
| – | | |
| 1,554,000 | | |
| – | | |
| 2,114,000 | |
| Net loss attributable to common shareholders | |
$ | (68,959,000 | ) | |
$ | (860,000 | ) | |
$ | (937,692,000 | ) | |
$ | (3,020,000 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Denominator: | |
| | | |
| | | |
| | | |
| | |
| Weighted average common shares outstanding | |
| 86,694,000 | | |
| 1,114,000 | | |
| 93,588,000 | | |
| 1,105,000 | |
| Dilutive common share equivalents | |
| – | | |
| – | | |
| – | | |
| – | |
| Weighted average dilutive shares outstanding | |
| 86,694,000 | | |
| 1,114,000 | | |
| 93,588,000 | | |
| 1,105,000 | |
| | |
| | | |
| | | |
| | | |
| | |
| Basic (loss) / earnings per share: | |
| | | |
| | | |
| | | |
| | |
| Basic loss per share from continuing operations | |
$ | (0.80 | ) | |
$ | (2.17 | ) | |
$ | (10.02 | ) | |
$ | (4.65 | ) |
| Basic earnings per share from discontinued operations | |
| – | | |
| 1.40 | | |
| – | | |
| 1.92 | |
| Basic loss per share attributable to common shareholders | |
$ | (0.80 | ) | |
$ | (0.77 | ) | |
$ | (10.02 | ) | |
$ | (2.73 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Diluted (loss) / earnings per share: | |
| | | |
| | | |
| | | |
| | |
| Diluted loss per share from continuing operations | |
$ | (0.80 | ) | |
$ | (2.17 | ) | |
$ | (10.02 | ) | |
$ | (4.65 | ) |
| Diluted earnings per share from discontinued operations | |
| – | | |
| 1.40 | | |
| – | | |
| 1.92 | |
| Diluted loss per share attributable to common shareholders | |
$ | (0.80 | ) | |
$ | (0.77 | ) | |
$ | (10.02 | ) | |
$ | (2.73 | ) |
The following securities were excluded from the
calculation of diluted earnings per share for the three and nine months ended June 30, 2026 and 2025 because their inclusion would have
been anti-dilutive:
| Schedule of anti-dilutive shares | |
| |
| |
| |
|
| | |
For the Three Months Ended June 30, | |
For the Nine Months Ended June 30, |
| | |
2026 | |
2025 | |
2026 | |
2025 |
| Convertible preferred stock | |
| – | | |
| 879,000 | | |
| – | | |
| 879,000 | |
| Options and RSUs | |
| 2,763,000 | | |
| 169,000 | | |
| 2,763,000 | | |
| 169,000 | |
| Warrants | |
| 13,495,000 | | |
| 186,000 | | |
| 13,495,000 | | |
| 186,000 | |
| Total potentially dilutive shares | |
| 16,258,000 | | |
| 1,234,000 | | |
| 16,258,000 | | |
| 1,234,000 | |
|